Markets respond positively to ECO Animal Health results

AIM-listed veterinary pharmaceuticals firm ECO Animal Health (LON:EAH) saw the price of its shares rise by 4.12% to 366.50 (as of 14:30 BST) after reporting an 11% increase in sales for the year ended 31st March. Profits before taxation were up by 10% and total dividends increased by 20% to 11.04p.

CEO Marc Loomes commented: “These are credible results for a year that was adversely depressed by both ASF and a trade war between the USA and China, our two largest markets. We are confident that our accelerated development programmes in vaccines and other products will add long term growth. For the year ahead we expect to report continued growth and to perform in line with the Board’s expectations“.